With unique, data-driven development and commercialization strategies, the Company is overcoming complex drug development challenges to make new therapies available to the rare disease community ...

We need to move from short-term, small-scale partnership projects to long-term, transformational, multi-stakeholder partnerships with the potential for scalable impact. The recent launch of our ...